Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. more
Time Frame | RZLT | Sector | S&P500 |
---|---|---|---|
1-Week Return | -13.08% | 0.31% | -1.26% |
1-Month Return | 5.12% | 0.6% | -4.16% |
3-Month Return | -1.26% | -9.44% | -0.46% |
6-Month Return | -2.68% | -5.15% | 3.58% |
1-Year Return | 367.33% | 0.33% | 22.47% |
3-Year Return | 4.89% | 4.53% | 25.13% |
5-Year Return | -31.4% | 35.98% | 77.7% |
10-Year Return | -94.41% | 100.72% | 190.12% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Cost of Revenue | 18.00K | 303.00K | 256.00K | 382.00K | 36.00K | [{"date":"2020-06-30","value":4.71,"profit":true},{"date":"2021-06-30","value":79.32,"profit":true},{"date":"2022-06-30","value":67.02,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":9.42,"profit":true}] |
Gross Profit | (18.00K) | (303.00K) | (256.00K) | (382.00K) | (36.00K) | [{"date":"2020-06-30","value":-1800000,"profit":false},{"date":"2021-06-30","value":-30300000,"profit":false},{"date":"2022-06-30","value":-25600000,"profit":false},{"date":"2023-06-30","value":-38200000,"profit":false},{"date":"2024-06-30","value":-3600000,"profit":false}] |
Gross Margin | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | [{"date":"2020-06-30","value":null,"profit":false},{"date":"2021-06-30","value":null,"profit":false},{"date":"2022-06-30","value":null,"profit":false},{"date":"2023-06-30","value":null,"profit":false},{"date":"2024-06-30","value":null,"profit":false}] |
Operating Expenses | 20.52M | 22.38M | 41.61M | 55.99M | 70.42M | [{"date":"2020-06-30","value":29.14,"profit":true},{"date":"2021-06-30","value":31.78,"profit":true},{"date":"2022-06-30","value":59.09,"profit":true},{"date":"2023-06-30","value":79.51,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Operating Income | (20.52M) | (22.89M) | (41.84M) | (55.99M) | (70.42M) | [{"date":"2020-06-30","value":-2052100000,"profit":false},{"date":"2021-06-30","value":-2289400000,"profit":false},{"date":"2022-06-30","value":-4184300000,"profit":false},{"date":"2023-06-30","value":-5599000000,"profit":false},{"date":"2024-06-30","value":-7042300000,"profit":false}] |
Total Non-Operating Income/Expense | 376.00K | 1.68M | (944.00K) | 8.41M | 6.83M | [{"date":"2020-06-30","value":4.47,"profit":true},{"date":"2021-06-30","value":19.97,"profit":true},{"date":"2022-06-30","value":-11.22,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":81.25,"profit":true}] |
Pre-Tax Income | (20.33M) | (20.90M) | (41.06M) | (51.79M) | (68.46M) | [{"date":"2020-06-30","value":-2033300000,"profit":false},{"date":"2021-06-30","value":-2090200000,"profit":false},{"date":"2022-06-30","value":-4106000000,"profit":false},{"date":"2023-06-30","value":-5178700000,"profit":false},{"date":"2024-06-30","value":-6845900000,"profit":false}] |
Income Taxes | (297.00) | 375.00K | (2.28M) | (137.90K) | 69.71M | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":0.54,"profit":true},{"date":"2022-06-30","value":-3.27,"profit":false},{"date":"2023-06-30","value":-0.2,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Income After Taxes | (20.33M) | (21.28M) | (38.78M) | (51.65M) | (138.17M) | [{"date":"2020-06-30","value":-2033270300,"profit":false},{"date":"2021-06-30","value":-2127700000,"profit":false},{"date":"2022-06-30","value":-3878100000,"profit":false},{"date":"2023-06-30","value":-5164910500,"profit":false},{"date":"2024-06-30","value":-13816600000,"profit":false}] |
Income From Continuous Operations | (20.33M) | (20.90M) | (41.06M) | (51.79M) | (68.46M) | [{"date":"2020-06-30","value":-2033300000,"profit":false},{"date":"2021-06-30","value":-2090200000,"profit":false},{"date":"2022-06-30","value":-4106000000,"profit":false},{"date":"2023-06-30","value":-5178700000,"profit":false},{"date":"2024-06-30","value":-6845900000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (20.33M) | (21.28M) | (38.78M) | (51.79M) | (68.46M) | [{"date":"2020-06-30","value":-2033300000,"profit":false},{"date":"2021-06-30","value":-2127700000,"profit":false},{"date":"2022-06-30","value":-3878100000,"profit":false},{"date":"2023-06-30","value":-5178700000,"profit":false},{"date":"2024-06-30","value":-6845900000,"profit":false}] |
EPS (Diluted) | (3.60) | (2.72) | (2.74) | (1.00) | (1.33) | [{"date":"2020-06-30","value":-360.5,"profit":false},{"date":"2021-06-30","value":-272,"profit":false},{"date":"2022-06-30","value":-274,"profit":false},{"date":"2023-06-30","value":-100,"profit":false},{"date":"2024-06-30","value":-133,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
RZLT | |
---|---|
Cash Ratio | 13.55 |
Current Ratio | 13.79 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RZLT | |
---|---|
ROA (LTM) | -34.33% |
ROE (LTM) | -57.73% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RZLT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.08 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.92 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RZLT | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 2.43 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Rezolute Inc (RZLT) share price today is $4.72
Yes, Indians can buy shares of Rezolute Inc (RZLT) on Vested. To buy Rezolute Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RZLT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Rezolute Inc (RZLT) via the Vested app. You can start investing in Rezolute Inc (RZLT) with a minimum investment of $1.
You can invest in shares of Rezolute Inc (RZLT) via Vested in three simple steps:
The 52-week high price of Rezolute Inc (RZLT) is $6.19. The 52-week low price of Rezolute Inc (RZLT) is $0.92.
The price-to-earnings (P/E) ratio of Rezolute Inc (RZLT) is
The price-to-book (P/B) ratio of Rezolute Inc (RZLT) is 2.43
The dividend yield of Rezolute Inc (RZLT) is 0.00%
The market capitalization of Rezolute Inc (RZLT) is $273.49M
The stock symbol (or ticker) of Rezolute Inc is RZLT